Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/14540
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kirkwood, L. | - |
dc.contributor.author | Nation, R. | - |
dc.contributor.author | Reynolds, G. | - |
dc.contributor.author | Somogyi, A. | - |
dc.contributor.author | Sansom, L. | - |
dc.date.issued | 1996 | - |
dc.identifier.citation | Pharmaceutical Sciences, 1996; 2(6):299-303 | - |
dc.identifier.issn | 1356-6881 | - |
dc.identifier.uri | http://hdl.handle.net/2440/14540 | - |
dc.description.abstract | The oxidative metabolism of dihydrocodeine to nordihydrocodeine and dihydromorphine was studied in liver microsomes of female Dark-Agouti (cytochrome P450 2D1 (CYP2D1) deficient) and Sprague-Dawley rats. Evaluation of microsomal metabolism in these two rat strains is a useful in-vitro model to test possible substrates of polymorphic human cytochrome P450 2D6 (CYP2D6). Nordihydrocodeine formation rates were similar in both strains. Analysis of the Michaelis-Menten kinetics of dihydromorphine formation showed a significant difference (P < 0.05) between strains, with respect to Km (943 μM for Dark-Agouti; 123 μM for Sprague-Dawley), Vmax (0.925; 2.37 μmol min−1 g−1) and intrinsic clearance (0.986; 19.5 mL min−1 g−1). In Sprague-Dawley liver microsomes, dihydromorphine formation was suppressed by the CYP2D1 inhibitors, quinine and quinidine, at concentrations which had no effect on nordihydrocodeine formation. These in-vitro findings indicate that in rat liver microsomes the cytochrome P450 system is involved in dihydrocodeine metabolism to dihydromorphine and nordihydrocodeine and that CYP2D1 is involved in the O-demethylation to dihydromorphine but not the Af-demethylation to nordihydrocodeine. The results of this study are in agreement with recent in-vivo studies of dihydrocodeine metabolism in man which indicate CYP2D6 is the predominant enzyme catalysing dihydromorphine formation. | - |
dc.description.statementofresponsibility | Lynette C. Kirkwood, Roger L. Nation, Geoffrey D. Reynolds, Andrew A. Somogyi and Lloyd N. Sansom | - |
dc.language.iso | en | - |
dc.publisher | Royal Pharmaceutical Society of Great Britain | - |
dc.rights | © 1996 Pharmaceutical Sciences | - |
dc.title | Oxidative metabolism of dihydrocodeine in Dark- Agouti and Sprague-Dawley rat liver microsomes | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1111/j.2042-7158.1996.tb00616.x | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Somogyi, A. [0000-0003-4779-0380] | - |
Appears in Collections: | Aurora harvest 2 Pharmacology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.